
Prolia which would be soon available on the NHS will offer relief to sufferers of osteoporosis.
Osteoporosis is a disease of bones that leads to an increased risk of fractures.
Advertisement
The twice-yearly injection offers hope to the more than 100,000 people - most of whom are women - who suffer with osteoporosis but are unable to take existing medication.
Trials of the drug, Prolia, have shown it dramatically cuts the number of spine and hip fractures in women, and helps bones regrow, reports the Daily Express.
Patients do not need to go to hospital because it can be administered by a GP.
Juliet Comptson, professor of bone medicine at Cambridge University, said the jab is 'good news' for patients already suffering bone problems.
Source: ANI
Patients do not need to go to hospital because it can be administered by a GP.
Juliet Comptson, professor of bone medicine at Cambridge University, said the jab is 'good news' for patients already suffering bone problems.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News

Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.

The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.

The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.

Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.

The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.